Occudo Quantitative Strategies’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-170,830
Closed -$13.7M 885
2026
Q1
$13.7M Buy
170,830
+28,787
+20% +$2.16M 0.74% 18
2025
Q4
$11.2M Buy
142,043
+130,965
+1,182% +$10.4M 0.75% 23
2025
Q3
$912K Sell
11,078
-91,855
-89% -$7.23M 0.11% 261
2025
Q2
$8.28M Buy
+102,933
New +$7.94M 0.93% 17
2024
Q3
Sell
-19,247
Closed -$1.35M 904
2024
Q2
$1.35M Sell
19,247
-37,689
-66% -$2.69M 0.24% 116
2024
Q1
$4.22M Buy
56,936
+16,182
+40% +$1.13M 0.74% 16
2023
Q4
$2.7M Buy
+40,754
New +$2.55M 0.37% 70
2023
Q3
Sell
-25,768
Closed -$1.46M 1180
2023
Q2
$1.46M Sell
25,768
-128,484
-83% -$7.13M 0.15% 207
2023
Q1
$8.94M Buy
154,252
+104,705
+211% +$7.07M 0.81% 3
2022
Q4
$3.59M Buy
49,547
+37,322
+305% +$2.67M 0.42% 19
2022
Q3
$743K Buy
+12,225
New +$781K 0.06% 527
2022
Q2
Sell
-34,140
Closed -$2.4M 1283
2022
Q1
$2.4M Buy
+34,140
New +$2.31M 0.2% 122

Other funds holding MET

Occudo Quantitative Strategies's MET Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of MetLife (MET) in Q2 2026, closing a stake of 170,830 shares — an estimated $13.7M sold.

Occudo Quantitative Strategies first reported a position in MET in Q1 2022 and held it in 12 quarters. The position peaked at $13.7M in Q1 2026. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Occudo Quantitative Strategies reported no remaining MetLife position as of Q2 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 170,830 MetLife shares in Q2 2026, an estimated $13.7M.
  • Occudo Quantitative Strategies first reported a position in MetLife in Q1 2022 and held it in 12 quarters.
  • Occudo Quantitative Strategies's MetLife position peaked at $13.7M in Q1 2026.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.